Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that it will effect a 1-for ...
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...
New research highlights that men and women with alcohol dependence may need different treatment approaches due to distinct ...
Discover how hormonal and biochemical factors affect alcohol dependence in men and women, suggesting the need for ...
This year's cohort includes scholars pursuing careers in political science, molecular biology, mechanical engineering, and ...
Patients with sickle cell anemia (SCA) and persistent albuminuria (PA) exhibited significantly higher levels of urinary ...
Hosted on MSN7mon
A novel micrometer-thick porous coating with unparalleled biomarker detection abilitiesHowever, measuring multiple biomarkers from different molecular classes could inform more comprehensively ... consisted of cross-linked polymeric molecules of the blood protein albumin and contained ...
A new study reveals hormonal and biochemical factors that affect alcohol dependence (also known as Alcohol Use Disorder), suggesting that men and women with alcohol problems may benefit from different ...
SON-1010 is a targeted immune activation cancer therapy designed to turn ‘cold’ tumors ‘hot’Topline safety data of SB101 Phase 1 study expected ...
A new study reveals hormonal and biochemical factors that affect alcohol dependence (also known as Alcohol Use Disorder), suggesting that men and women with alcohol problems may benefit from different ...
Discover Equillium Inc.'s groundbreaking patent for a ?c cytokine antagonist peptide, offering new hope for treating alopecia and immune-mediated hair loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback